Moderna COVID-19 Vaccine 'Highly Effective,' Says FDA Analysis
Now we wait for the FDA to get around to approving it later this week.
Now we wait for the FDA to get around to approving it later this week.
Don't let stories of rare and dangerous side effects discourage you from getting immunized.
Full FDA approval is likely, and vaccinations could begin next week.
Some scientists offer an important reminder about cause and effect.
It is likely to be approved for distribution by the end of the week.
It's not like we're in the middle of a pandemic or anything, right?
Companies plan to seek emergency use authorization from the FDA almost immediately.
Plus: Pennsylvania Supreme Court rejects Trump campaign complaint, new pandemic restrictions in lots of states, and more...
Plus: Trump says he plans to hold rallies despite lack of negative COVID-19 test, Biden won't answer question on court-packing, and more...
Yes, but the Trump administration's politicization of the hunt for a vaccine is undermining public trust.
COVID-19 testing is not "overrated."
Polls show a country increasingly leery of a politicized COVID-19 vaccine approval process.
In interviews with Bob Woodward, the president said he knew COVID-19 was much more serious than he let on.
The industry's fate depends on the whims of an agency charged with deciding what is "appropriate for public health."
"Economists are accustomed to thinking about tradeoffs," says economist and Nobel laureate Alvin Roth. "It appears that at least in some parts of the ethics community, they are not."
67 percent say they would get vaccinated as soon as an inoculation becomes available.
A new study suggests that a second higher wave of infections can be avoided.
The study suggests that vaping raises your risk of catching the disease, but only if you stop.
With antigen testing, the U.S. could have been well on its way toward crushing the pandemic by now.
Past attempts to reduce foodborne illnesses haven't worked. Will a focus on technology make this effort any different?
It’s a new era of digital therapeutics—and a reminder of how burdensome the federal regulatory process is.
The flexibility will allow food makers to substitute small amounts of food ingredients temporarily without necessitating the creation or use of a new food label.
The hemp boom has failed to materialize, and regulatory uncertainty is to blame.
Early takeaways from the country's response to a pandemic
Also included is an "alternative facts" narrative of federal government testing screw-ups since January.
Dairy industry-endorsed regulations required skim milk to be labeled as “imitation” if it hadn’t been enriched with added vitamins.
Health care expert Avik Roy says that even without widespread testing, it's time to reopen schools and allow healthy, younger employees to go back to work.
"The more we lock down the economy, the more we harm those individuals who are most vulnerable, who don't have the cash cushions or the white-collar jobs that allow them to keep going."
The FDA has relaxed some labeling laws in order to allow restaurants to sell groceries, but it could do more.
They ignored early warning signs and pretended that everything would be OK.
From March 26 to April 8, the number of projected deaths from coronavirus dropped from 81,000 to 60,000. What should we do with such information?
The Multidisciplinary Association for Psychedelic Studies (MAPS) is making MDMA and other drugs medically legitimate and socially acceptable.
The failure to conduct early and wide testing left politicians ignorant of basic facts about the COVID-19 epidemic.
"We're not going to be looking back," said House Majority Whip Jim Clyburn.
The problems with the federal response to COVID-19 go far beyond Donald Trump and deep into bureaucratic inertia.
Health care workers will now be allowed to use the Chinese-certified KN95 masks, which are equivalent to the N95 masks that are in short supply.
The Duke economist and political scientist discusses the response to COVID-19, the coming recession, and the end of higher ed as we know it.
The agency has hampered widespread COVID-19 testing and the production of both protective gear and hand sanitizer.
Before this, the wait period was a year.
Rules designed to keep alcohol safe for children are slowing down production of a product that’s in short supply.
The renowned science writer talks about pandemics, Chinese authoritarianism, Brexit, and why the freedom to innovate must not be quashed.
The Kentucky congressman who insisted Congress record its vote on history's biggest spending bill is unapologetic and outspoken about limited government.
Markets are trying to meet spiking demand for face masks, but importers are stymied by the FDA and CDC
The Kentucky Republican took on Donald Trump and Nancy Pelosi to fight against the $2 trillion coronavirus spending package. He's just getting started.
DIY manufacturers scramble to reduce shortages, as public health officials send mixed messages about the efficacy of broader use.
They were mocked for sounding the alarm. Now they're the ones providing the solutions.
The agency should relax the yearlong deferral period.
The agency concludes that the possible benefits outweigh the risks.
Do you care about free minds and free markets? Sign up to get the biggest stories from Reason in your inbox every afternoon.
This modal will close in 10